Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Passage Bio, Inc. - Common Stock (NQ:PASG)

7.920 -0.200 (-2.46%)
Streaming Delayed Price Updated: 2:32 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Passage Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
From Passage Bio
Via GlobeNewswire
News headline image
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
News headline image
Recap: Passage Bio Q3 Earnings ↗
 
Via Benzinga
News headline image
Recap: Passage Bio Q1 Earnings ↗
 
Via Benzinga
News headline image
Passage Bio's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
From Passage Bio
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study
From Passage Bio
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Passage Bio to Participate in Upcoming Investor Conferences
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗
The Dow Jones closed higher by over 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 64 companies achieved new lows for the year. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 33 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
From Passage Bio
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 89 stocks made new 52-week lows. 
Via Benzinga
News headline image
Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio to Present at Cowen 43rd Annual Health Care Conference
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023
From Passage Bio
Via GlobeNewswire
News headline image
Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023
From Passage Bio
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.